ChemicalBook >> CAS DataBase List >>OICR-9429

OICR-9429

CAS No.
1801787-56-3
Chemical Name:
OICR-9429
Synonyms
CS-2362;OICR-9429;OICR-9429 (OICR9429;OICR-9429, 10 mM in DMSO;6-hydroxy-N-(4-(4-methylpiperazin-1-yl)-3'-(morpholinomethyl)-[1,1'-biphenyl]-3-yl)-4-(trifluoromethyl)nicotinamide;N-[2-(4-methylpiperazin-1-yl)-5-[3-(morpholin-4-ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1H-pyridine-3-carboxamide;N-[2-(4-Methylpiperazin-1-yl)-5-[3-(morpholin-4-ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide;N-(4-(4-methylpiperazin-1-yl)-3'-(morpholinomethyl)-[1,1'-biphenyl]-3-yl)-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide;3-Pyridinecarboxamide, 1,6-dihydro-N-[4-(4-methyl-1-piperazinyl)-3'-(4-morpholinylmethyl)[1,1'-biphenyl]-3-yl]-6-oxo-4-(trifluoromethyl)-;OICR9429,pancreatic,Histone Methyltransferase,MLL,inhibit,OICR-9429,colon,prostate cance,bladder cancer (BCa),Inhibitor,WD repeat domain 5 (WDR5),Apoptosis,leukaemia,H3K4
CBNumber:
CB43133471
Molecular Formula:
C29H32F3N5O3
Molecular Weight:
555.59
MDL Number:
MFCD28411621
MOL File:
1801787-56-3.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-08-20 20:20:01

OICR-9429 Properties

Boiling point 693.0±55.0 °C(Predicted)
Density 1.325±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility insoluble in EtOH; insoluble in H2O; ≥21.52 mg/mL in DMSO
form powder
pka 8.84±0.10(Predicted)
color white to light brown
InChI 1S/C7H5FN2O2/c1-2-3-10-4-5(8)6(11)9-7(10)12/h1,4H,3H2,(H,9,11,12)
InChIKey DJOVLOYCGXNVPI-UHFFFAOYSA-N
SMILES C1NC(=O)C=C(C(F)(F)F)C=1C(NC1C(N2CCN(C)CC2)=CC=C(C2=CC=CC(CN3CCOCC3)=C2)C=1)=O
UNSPSC Code 12352200
NACRES NA.77

SAFETY

Risk and Safety Statements

Symbol(GHS)  Exclamation Mark (GHS07)
GHS07
Signal word  Warning
Hazard statements  H315
Precautionary statements  P264-P302+P352-P321-P332+P313-P362+P364
WGK Germany  WGK 3
Storage Class 11 - Combustible Solids
Hazard Classifications Skin Irrit. 2
NFPA 704
0
1 0

OICR-9429 price More Price(43)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML1209 OICR-9429 ≥98% (HPLC) 1801787-56-3 5MG $217 2026-04-30 Buy
Sigma-Aldrich SML1209 OICR-9429 ≥98% (HPLC) 1801787-56-3 25MG $696 2022-05-15 Buy
Cayman Chemical 16095 OICR-9429 ≥98% 1801787-56-3 1mg $63 2026-04-30 Buy
Cayman Chemical 16095 OICR-9429 ≥98% 1801787-56-3 5mg $168 2026-04-30 Buy
Cayman Chemical 16095 OICR-9429 ≥98% 1801787-56-3 10mg $242 2026-04-30 Buy
Product number Packaging Price Buy
SML1209 5MG $217 Buy
SML1209 25MG $696 Buy
16095 1mg $63 Buy
16095 5mg $168 Buy
16095 10mg $242 Buy

OICR-9429 Chemical Properties, Uses, Production

Uses

OICR-9429 is a chemical probe which inhibits the interaction of WDR5 (WD-repeat Protein 5) with peptide regions of MLL and Histone 3 with high selectivity. WDR5 is a part of the mixed-lineage leukemia (MLL) transferase complex that targets histone 3.

Biological Activity

oicr-9429 is an antagonist of wdr5-mll interaction.wdr5 has been identified as a component of the mll complex, which is required for histone h3 tri-methylation by its binding of histone h3. thus, wdr5 is reported to be a presenter component of mll, suggesting that wdr5 can bind substrates of methylated histone h3 to the mll complex for further methylation.

Biochem/physiol Actions

OICR-9429 is a cell penetrant, potent and selective antagonist of the interaction of WDR5 (WD repeat domain 5) with peptide regions of MLL and Histone 3 that potently binds to WDR5. OICR-9429 inhibits the interaction of WDR5 with MLL1 and RbBP5 in cells. For full characterization details, please see OICR-9429 on the Structural Genomics Consortium (SGC) website.OICR-0547 is the negative control for the active probe, OICR-9429. To request a sample of the negative control from the SGC, click here.To learn about other SGC chemical probes for epigenetic targets, visit sigma.com/sgc

in vitro

previous study found that wdr5 could be detected readily in c/ebpα immunoprecipitates from lysates of cebpap30/p30 cells by the treatment of oicr-9429, indicating that the wdr5-mll interaction could not influence p30 binding. moreover, the gene expression profiling of oicr-9429-treated cebpap30/p30 cells showed that wdr5 antagonism could result in the upregulation of myeloid-specific transcripts. in addition, the gene set enrichment analyses demonstrated a close correlation between oicr-9429–induced genes and genes that were upregulated after wdr5 knockdown. furthermore, the gene profile of cebpap30/p30 lics6 was downregulated due to the wdr5 antagonism caused by oicr-9429. further treatment of oicr-9429 to cebpap30/p30 cells was found to be associated with myeloid differentiation and loss of progenitor morphology [1].

IC 50

5 um

storage

Store at -20°C

References

[1] FLORIAN GREBIEN. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia[J]. Nature chemical biology, 2015, 11 8: 571-578. DOI:10.1038/nchembio.1859.
[2] DONG A, DOMBROVSKI L, WALKER J, et al. Crystal structure of human WDR5 in complex with compound OICR-9429[C]. 2014: 0. DOI:10.2210/pdb4ql1/pdb.
[3] MATTHUS GETLIK. Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1)[J]. Journal of Medicinal Chemistry, 2016, 59 6: 2478-2496. DOI:10.1021/acs.jmedchem.5b01630.

OICR-9429 Preparation Products And Raw materials

Raw materials

Preparation Products

Global Suppliers ( 120)
Supplier Tel Email Country ProdList Advantage
Chengdu PEIP Pharmaceutical Technology Co., LTD. 028-61715638 18011352545 1242335275@qq.com China 473 58
Shanghai Boyle Chemical Co., Ltd. sales@boylechem.com China 2915 55
MedChemexpress LLC 021-58955995 sales@medchemexpress.cn United States 4853 58
Bide Pharmatech Ltd. 400-164-7117 18317119277 product02@bidepharm.com China 40000 60
Mashilabs (Shanghai) Co.,Ltd. 19916721580 mafarm@126.com China 4534 58
Sigma-Aldrich 021-61415566 800-8193336 orderCN@merckgroup.com China 51389 80
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4858 55
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9799 58
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62

View Latest Price from OICR-9429 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
OICR-9429 pictures 2026-08-19 OICR-9429
1801787-56-3
$31.00-68.00 97.07% 10g TargetMol Chemicals Inc.
OICR-9429 pictures 2026-08-15 OICR-9429
1801787-56-3
1KG 98 1000 KG Shaanxi Dideu New Materials Co. Ltd
  • OICR-9429 pictures
  • OICR-9429
    1801787-56-3
  • $31.00-68.00
  • 97.07%
  • TargetMol Chemicals Inc.
  • OICR-9429 pictures
  • OICR-9429
    1801787-56-3
  • $0.00
  • 98
  • Shaanxi Dideu New Materials Co. Ltd
CS-2362 OICR-9429 (OICR9429 N-[2-(4-Methylpiperazin-1-yl)-5-[3-(morpholin-4-ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide N-(4-(4-methylpiperazin-1-yl)-3'-(morpholinomethyl)-[1,1'-biphenyl]-3-yl)-6-oxo-4-(trifluoromethyl)-1,6-dihydropyridine-3-carboxamide 6-hydroxy-N-(4-(4-methylpiperazin-1-yl)-3'-(morpholinomethyl)-[1,1'-biphenyl]-3-yl)-4-(trifluoromethyl)nicotinamide 3-Pyridinecarboxamide, 1,6-dihydro-N-[4-(4-methyl-1-piperazinyl)-3'-(4-morpholinylmethyl)[1,1'-biphenyl]-3-yl]-6-oxo-4-(trifluoromethyl)- N-[2-(4-methylpiperazin-1-yl)-5-[3-(morpholin-4-ylmethyl)phenyl]phenyl]-6-oxo-4-(trifluoromethyl)-1H-pyridine-3-carboxamide OICR9429,pancreatic,Histone Methyltransferase,MLL,inhibit,OICR-9429,colon,prostate cance,bladder cancer (BCa),Inhibitor,WD repeat domain 5 (WDR5),Apoptosis,leukaemia,H3K4 OICR-9429 OICR-9429, 10 mM in DMSO 1801787-56-3 C29H32F3N5O3 API